The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome
Open accessAbstract
Marfan syndrome is a connective tissue disorder caused by mutations in the gene encoding fibrillin-1 (FBN1). A dominant-negative mechanism has been inferred based upon dominant inheritance, mulitimerization of monomers to form microfibrils, and the dramatic paucity of matrix-incorporated fibrillin-1 seen in heterozygous patient samples. Yeast artificial chromosome-based transgenesis was used to overexpress a disease-associated mutant form of human fibrillin-1 (C1663R) on a normal mouse background. Remarkably, these mice failed to show any abnormalities of cellular or clinical phenotype despite regulated overexpression of mutant protein in relevant tissues and developmental stages and direct evidence that mouse and human fibrillin-1 interact with high efficiency. Immunostaining with a human-specific mAb provides what we believe to be the first demonstration that mutant fibrillin-1 can participate in productive microfibrillar assembly. Informatively, use of homologous recombination to generate mice heterozygous for a comparable missense mutation (C1039G) revealed impaired microfibrillar deposition, skeletal deformity, and progressive deterioration of aortic wall architecture, comparable to characteristics of the human condition. These data are consistent with a model that invokes haploinsufficiency for WT fibrillin-1, rather than production of mutant protein, as the primary determinant of failed microfibrillar assembly. In keeping with this model, introduction of a WT FBN1 transgene on a heterozygous C1039G background rescues aortic phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene
Dietz, H. C., Cutting, C. R., Pyeritz, R. E., Maslen, C. L., Sakai, L. Y., Corson, G. M., Puffenberger, E. G., Hamosh, A., Nanthakumar, E. J., Curristin, S. M., et al. (1991) · Nature · doi:10.1038/352337a0 · Cited by 2,070
Self-citationDysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome
Neptune, E. R., Frischmeyer, P. A., Arking, D. E., Myers, L., Bunton, T. E., Gayraud, B., Ramirez, F., Sakai, L. Y., & Dietz, H. C. (2003) · Nature Genetics · doi:10.1038/ng1116 · Cited by 1,404
Self-citationFibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils.
Sakai, L. Y., Keene, D. R., & Engvall, E. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2499 · Cited by 1,157
Self-citationNonsense-mediated mRNA decayin health and disease
Frischmeyer, P. A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.10.1893 · Cited by 992
Life expectancy in the Marfan syndrome
Silverman, D. I., Burton, K. J., Gray, J., Bosner, M. S., Kouchoukos, N. T., Roman, M. J., Boxer, M., Devereux, R. B., & Tsipouras, P. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)80066-1 · Cited by 565
Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1
Pereira, L., Lee, S. Y., Gayraud, B., Andrikopoulos, K., Shapiro, S. D., Bunton, T., Biery, N. J., Dietz, H. C., Sakai, L. Y., & Ramirez, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3819 · Cited by 549
Self-citationLife expectancy in the marfan syndrome
(1996) · ACC Current Journal Review · doi:10.1016/1062-1458(96)82279-3 · Cited by 481
THE FINE STRUCTURE OF ELASTIC FIBERS
Greenlee, T. K., Ross, R., & Hartman, J. L. (1966) · The Journal of Cell Biology · doi:10.1083/jcb.30.1.59 · Cited by 416
Targetting of the gene encoding fibrillin–1 recapitulates the vascular aspect of Marfan syndrome
Pereira, L., Andrikopoulos, K., Tian, J., Lee, S. Y., Keene, D. R., Ono, R., Reinhardt, D. P., Sakai, L. Y., Biery, N. J., Bunton, T., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-218 · Cited by 407
Self-citation
Cited by
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794
Self-citationTGF-β and the TGF-β family: context-dependent roles in cell and tissue physiology
Morikawa, M., Derynck, R., & Miyazono, K. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021873 · Cited by 1,321
Judge, D. P., & Dietz, H. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67789-6 · Cited by 1,210
Self-citationExtracellular control of TGFβ signalling in vascular development and disease
ten Dijke, P., & Arthur, H. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2262 · Cited by 778
Cohn, R. D., van Erp, C., Habashi, J. P., Soleimani, A. A., Klein, E. C., Lisi, M. T., Gamradt, M., ap Rhys, C. M., Holm, T. M., Loeys, B. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1536 · Cited by 669
Self-citationFaivre, L., Collod-Beroud, G., Loeys, B. L., Child, A., Binquet, C., Gautier, E., Callewaert, B., Arbustini, E., Mayer, K., Arslan-Kirchner, M., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/520125 · Cited by 613
Self-citationTGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome
Ng, C. M., Cheng, A., Myers, L. A., Martinez-Murillo, F., Jie, C., Bedja, D., Gabrielson, K. L., Hausladen, J. M. W., Mecham, R. P., Judge, D. P., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422715 · Cited by 588
Self-citationAnimal models of atherosclerosis
Emini Veseli, B., Perrotta, P., De Meyer, G. R. A., Roth, L., Van der Donckt, C., Martinet, W., & De Meyer, G. R. Y. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.010 · Cited by 548
Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm
Lindsay, M. E., Schepers, D., Bolar, N. A., Doyle, J. J., Gallo, E., Fert-Bober, J., Kempers, M. J. E., Fishman, E. K., Chen, Y., Myers, L., et al. (2012) · Nature Genetics · doi:10.1038/ng.2349 · Cited by 482
Self-citationNoncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice
Holm, T. M., Habashi, J. P., Doyle, J. J., Bedja, D., Chen, Y., van Erp, C., Lindsay, M. E., Kim, D., Schoenhoff, F., Cohn, R. D., et al. (2011) · Science · doi:10.1126/science.1192149 · Cited by 476
Self-citationAngiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism
Habashi, J. P., Doyle, J. J., Holm, T. M., Aziz, H., Schoenhoff, F., Bedja, D., Chen, Y., Modiri, A. N., Judge, D. P., & Dietz, H. C. (2011) · Science · doi:10.1126/science.1192152 · Cited by 472
Self-citationMolecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
Cellular Mechanisms of Aortic Aneurysm Formation
Quintana, R. A., & Taylor, W. R. (2019) · Circulation Research · doi:10.1161/circresaha.118.313187 · Cited by 435
The molecular genetics of Marfan syndrome and related disorders
Robinson, P. N., Arteaga-Solis, E., Baldock, C., Collod-Béroud, G., Booms, P., De Paepe, A., Dietz, H. C., Guo, G., Handford, P. A., Judge, D. P., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.039669 · Cited by 430
Self-citationElastic fibres in health and disease
Baldwin, A. K., Simpson, A., Steer, R., Cain, S. A., & Kielty, C. M. (2013) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2013.9 · Cited by 427
Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
Robertson, I. B., & Rifkin, D. B. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021907 · Cited by 403
Groenink, M., den Hartog, A. W., Franken, R., Radonic, T., de Waard, V., Timmermans, J., Scholte, A. J., van den Berg, M. P., Spijkerboer, A. M., Marquering, H. A., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht334 · Cited by 396
FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders
Sakai, L. Y., Keene, D. R., Renard, M., & De Backer, J. (2016) · Gene · doi:10.1016/j.gene.2016.07.033 · Cited by 342
Self-citationMilewicz, D. M., Braverman, A. C., De Backer, J., Morris, S. A., Boileau, C., Maumenee, I. H., Jondeau, G., Evangelista, A., & Pyeritz, R. E. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00298-7 · Cited by 305
Circulating Transforming Growth Factor-β in Marfan Syndrome
Matt, P., Schoenhoff, F., Habashi, J., Holm, T., Van Erp, C., Loch, D., Carlson, O. D., Griswold, B. F., Fu, Q., De Backer, J., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.841981 · Cited by 274
Self-citationHereditary Influence in Thoracic Aortic Aneurysm and Dissection
Isselbacher, E. M., Lino Cardenas, C. L., & Lindsay, M. E. (2016) · Circulation · doi:10.1161/circulationaha.116.009762 · Cited by 262
Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma
Gerber, E. E., Gallo, E. M., Fontana, S. C., Davis, E. C., Wigley, F. M., Huso, D. L., & Dietz, H. C. (2013) · Nature · doi:10.1038/nature12614 · Cited by 190
“Positive clones were identified by Southern blot analysis (Figure S1B) as previously described [1].”
MethodSelf-citationZilberberg, L., Todorovic, V., Dabovic, B., Horiguchi, M., Couroussé, T., Sakai, L. Y., & Rifkin, D. B. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24094 · Cited by 181
“Mice heterozygous for theC1039G mutation (Fbn1C1039G/þ) display MFS-like phenotypic manifestations in the pulmonary, cardiovascular and skeletal systems (Judge et al., 2004).”
BackgroundSelf-citationOller, J., Méndez-Barbero, N., Ruiz, E. J., Villahoz, S., Renard, M., Canelas, L. I., Briones, A. M., Alberca, R., Lozano-Vidal, N., Hurlé, M. A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4266 · Cited by 177
An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm
Lino Cardenas, C. L., Kessinger, C. W., Cheng, Y., MacDonald, C., MacGillivray, T., Ghoshhajra, B., Huleihel, L., Nuri, S., Yeri, A. S., Jaffer, F. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03394-7 · Cited by 150
The Haploinsufficient Col3a1 Mouse as a Model for Vascular Ehlers-Danlos Syndrome
Cooper, T. K., Zhong, Q., Krawczyk, M., Tae, H.-J., Müller, G. A., Schubert, R., Myers, L. A., Dietz, H. C., Talan, M. I., & Briest, W. (2010) · Veterinary Pathology · doi:10.1177/0300985810374842 · Cited by 51
Self-citationMeirelles, T., Araujo, T. L. S., Nolasco, P., Moretti, A. I. S., Guido, M. C., Debbas, V., Pereira, L. V., & Laurindo, F. R. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.12.009 · Cited by 10
Metadata
- Authors
- Judge, D. P., Biery, N. J., Keene, D. R., Geubtner, J., Myers, L., Huso, D. L., Sakai, L. Y., & Dietz, H. C.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-07-15
- Volume
- 114
- Issue
- 2
- Pages
- 172-181
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2136335783
- Cited by
- 475
- References
- 43
- FWCI
- 7.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.